Premium Nahrungsergänzungsmittel | artgerecht

Acne Papulopustulosa – Causes, Symptoms and Treatment

Acne papulopustulosa is a moderate form of acne characterised by inflamed papules and pus-filled pustules. It is caused by clogged pores, bacterial activity, and skin inflammation.

Regular tips about health Regular tips about health

Things worth knowing about "Acne papulopustulosa"

Acne papulopustulosa is a moderate form of acne characterised by inflamed papules and pus-filled pustules. It is caused by clogged pores, bacterial activity, and skin inflammation.

What is Acne papulopustulosa?

Acne papulopustulosa, also referred to as papulopustular acne, is an inflammatory skin condition classified as a moderate form of acne vulgaris. It is defined by the simultaneous presence of papules (red, raised, solid bumps without a visible pus centre) and pustules (pus-filled lesions surrounded by inflamed skin). These lesions most commonly appear on the face, chest, and back, and can be tender or painful to the touch.

Causes

Acne papulopustulosa develops through a combination of interconnected factors:

Excess sebum production: Overactive sebaceous glands produce too much oil, leading to clogged hair follicles.
Follicular hyperkeratosis: Abnormal shedding of skin cells inside the follicle blocks the pore and forms comedones.
Bacterial colonisation: The bacterium Cutibacterium acnes (formerly Propionibacterium acnes) proliferates within blocked follicles, triggering an inflammatory immune response.
Hormonal influences: Androgens such as testosterone stimulate sebaceous gland activity, which is why acne frequently begins during puberty.
Genetic predisposition: A family history of acne is a known risk factor.
External triggers: Stress, comedogenic cosmetics, certain dietary patterns, and some medications may worsen acne.

Symptoms

The hallmark features of acne papulopustulosa include:

Papules: Small, firm, red bumps caused by inflamed or infected hair follicles.
Pustules: White or yellow-tipped, pus-filled lesions surrounded by redness.
Comedones: Open (blackheads) or closed (whiteheads) clogged pores often present alongside inflammatory lesions.
Tenderness and pain: Inflamed lesions may be sensitive or painful when touched.
Scarring: Improper treatment or picking at lesions can result in permanent scars or post-inflammatory hyperpigmentation.
Psychological impact: Visible skin lesions can significantly affect self-esteem and quality of life, particularly in adolescents and young adults.

Diagnosis

Diagnosis of acne papulopustulosa is primarily clinical, based on a physical examination by a dermatologist or general practitioner. The type, number, and distribution of lesions are assessed and graded using validated severity scales such as the IGA (Investigator Global Assessment) or the Leeds Revised Acne Grading System. Laboratory tests are generally not required for a straightforward diagnosis but may be indicated when a hormonal underlying condition (e.g., polycystic ovary syndrome) is suspected.

Treatment

Treatment of acne papulopustulosa is tailored to the severity of the condition and typically follows a stepwise approach.

Topical Treatments

Benzoyl peroxide (BPO): Acts as an antibacterial and keratolytic agent; commonly used as a first-line option for mild to moderate acne.
Topical retinoids (e.g., adapalene, tretinoin): Regulate follicular keratinisation and reduce comedone formation.
Topical antibiotics (e.g., clindamycin, erythromycin): Reduce bacterial load and inflammation; usually combined with BPO to minimise antibiotic resistance.
Azelaic acid: Offers anti-inflammatory, antibacterial, and skin-lightening effects, useful for post-inflammatory hyperpigmentation.

Systemic Treatments

Oral antibiotics (e.g., doxycycline, lymecycline): Recommended for moderate to severe acne; typical treatment duration is 3 to 6 months.
Combined oral contraceptives: Certain formulations can be effective in women with hormonally driven acne.
Oral isotretinoin: Reserved for severe or treatment-resistant acne; highly effective but subject to strict prescribing guidelines due to teratogenicity.

Supportive Measures

Use of gentle, non-comedogenic skincare products
Avoiding excessive washing or scrubbing of affected skin
Refraining from squeezing or picking at lesions to prevent scarring and secondary infection
Dietary considerations: some evidence suggests a link between high-glycaemic foods and dairy intake and acne severity

References

Nast A. et al. - European evidence-based (S3) guideline for the treatment of acne. Journal of the European Academy of Dermatology and Venereology, 2016/2022.
Zaenglein A.L. et al. - Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology, 2016;74(5):945-973.
Plewig G., Melnik B., Chen W. - Plewig and Kligman's Acne and Rosacea. Springer, 4th edition, 2019.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.